Read the latest articles featuring MTPConnect.
Mirage News | 15 January 2022
The University of Sydney | 14 January 2022
Monash University | 14 January 2022
The Canberra Times | 14 January 2022
The Department of Health - Media release | 14 January 2022
Australian Manufacturing Technology | 30 November 2021
BiotechDispatch | 11 November 2021
AMTIL In Industry News | 04 November 2021
Business News | 04 November 2021
cannabiz | 26 October 2021
Department of Industry, Science, Energy and Resources | 07 October 2021
The Australian | 27 September 2021
Aged Care News | 27 September 2021
BioPharma Dispatch | 24 September 2021
Pulse+IT | 23 August 2021
InnovationAus | 20 August 2021
BioPharmaDispatch | 13 August 2021
Biotech Dispatch | 12 August 2021
InnovationAus | 09 August 2021
Pharma in Focus | 04 August 2021
InnovationAus | 04 August 2021
Mirage News | 03 August 2021
Biotech Dispatch | 29 July 2021
Manufacturers Monthly | 23 July 2021
InnovationAus | 23 July 2021
Kalkin Media | 22 July 2021
Pharma In Focus | 21 July 2021
MedNews | 21 July 2021
InnovationAus | 20 July 2021
Manufacturing Magazine Industry Update | 20 July 2021
ABC Radio Nightlife | 19 July 2021
InnovationAus | 19 July 2021
Health Dispatch | 14 July 2021
Grit Daily | 06 July 2021
SMH | 04 July 2021
Innovation Aus | 07 June 2021
AuManufacturing | 31 May 2021
Innovation Aus | 24 May 2021
BioPharma Dispatch | 21 May 2021
AusInnovation | 20 May 2021
Half a decade of domestic growth in the clinical trials sector has failed to attract a greater share of global industry-sponsored trials to Australia, according to a new report from the MedTech and pharmaceutical growth centre, which touts the sector’s potential in the COVID recovery.
Startup News WA | 19 May 2021
Manufacturers Monthly | 17 May 2021
MTPConnect, Australia’s growth centre for medical technologies and pharmaceuticals sector, has launched a new voucher program to boost the manufacture of medical products in Western Australia.
AusInnovation | 17 May 2021
Western Australian developers and manufacturers can now apply for up to $100,000 in matched government funding for medical technology and pharmaceutical manufacturing projects.
AuManufacturing | 14 May 2021
BiotechDispatch | 13 May 2021
Health Industry Hub | 13 May 2021
Bioworld | 10 May 2021
Health Industry Hub | 03 May 2021
BioPharmaDispatch | 11 March 2021
MTPConnect released the second of three reports examining skills gaps in the medical technology, biotechnology and pharmaceutical (MTP) sector workforce and identified 20 skills gaps. The reports are being developed as part of the Researcher Exchange and Development within Industry (REDI) initiative, operated by MTPConnect for the Medical Research Future Fund.
Department of Health | 12 January 2021
MTPConnect, together with the Minister for Health & Aged Care, Hon. Greg Hunt MP announced that that the Targeted Translation Research Accelerator (TTRA) initiative for diabetes and cardiovascular disease is calling for Expressions of Interest (EOI) for two new Research Centres and the first round of Research Projects funding.
Biotech Dispatch | 19 November 2020
MTPConnect announced that GSK Australia had joined the REDI initiative as a partner to fun its new PhD Graduate Innovation Program.
Biotech Dispatch | 29 October 2020
MTPConnect announced partners for its TTRA initiative - ANDHealth, the Medical Device Partnering Program (MDPP) and UniQuest that will provide advice and mentoring for funding recipients.
Biotech Dispatch | 29 October 2020
MTPConnect announced that it had awarded Industry Growth Centre funding to establish a regenerative medicine consortium led by AusBiotech with six industry partners.
Biotech Dispatch | 15 October 2020
MTPConnect welcomed the funding for a new manufacturing facility at the Translational Research Institute (TRI) in Brisbane.
Stockhead | 7 October 2020
MTPConnect, in partnership with L.E.K. Consulting, released the second edition of the COVID-19 Impact Report to explore the strategies to spur recovery and discusses trends and opportunities for growth. The report makes it clear that the MTP sector has a critical and ongoing role to play in pandemic response, future preparedness and economic recovery.
The Australian | 24 September 2020
MTPConnect, with support from Pfizer, MSD Australia, GSK Australia and Medicines Australia launched Australia's first Antimicrobial Resistance Network – the AAMRNet, and released a new report, ‘Fighting Superbugs: A Report on the Inaugural Meeting of Australia’s Antimicrobial Resistance Stakeholders'.
The Australian | 3 September 2020
The article covers the announcement of BTB Round 2 & 3 funding to 13 early stage medical research projects.
Department of Health | 3 September 2020
MTPConnect joined Minister for Health Hon. Greg Hunt MP, in the announcement of 13 early-stage medical research projects (including 5 COVID-19 projects), recieving $10.4 million in funding from BTB Rounds 2 & 3.
AMTIL Magazine | 6 August 2020
Queensland's University of Technology (QUT)'s BridgeTech Program was highlighted in AMTIL's latest issue. BridgeTech is funded by MTPConnect with the REDI initiative.
Australian Manufacturing | 20 July 2020
MTPConnect announced the promising 21 research projects, funded under the third round of the BioMedTech Horizons program.
BiotechDispatch | 14 July 2020
MTPConnect launched its $47 million Targeted Translation Research Accelerator (TTRA) for Diabetes and Cardiovascular Disease, an initiative of the Medical Research Future Fund (MRFF), operated by MTPConnect.
Department of Industry, Science, Energy and Resources | 13 July 2020
The Minister for Industry, Science and Technology Hon. Karen Andrews MP joined Minister for Health Hon. Greg Hunt MP in the announcement of the new $47 million Targeted Translation Research Accelerator (TTRA) initiative for diabetes and cardiovascular disease, awarded to MTPConnect.
Australian Financial Review | 13 July 2020
Our Managing Director & CEO Dr Dan Grant spoke about the potential for the MTP sector to develop in the short term post COVID-19 and more.
Australian Financial Review | 17 June 2020
Our Managing Director & CEO Dr Dan Grant highlighted our COVID-19 Impact Reports and the way our MTP sector and government are coming together to combat the global pandemic.
Innovation Aus | 18 May 2020
The call out for the third round of our Biomedical Translation Bridge (BTB) program, was centered around responding to the global pandemic in 12 months or less.
Innovation Aus | 1 March 2020
Our Chair Sue MacLeman, was appointed to the Prime Ministers Digital Health Advisory Committee.
Department of Health | 5 February 2020
MTPConnect along with our partners, were awarded REDI, a new MRFF program.
Biotech Dispatch | 21 January 2020
Biotech Dispatch covered the announcement of our new Board member Alex Fowkes.
Sydney Morning Herald | 16 January 2020
Noisy Guts, a WA-based start-up, was awarded funding in the first round of our Biomedical Translation Bridge (BTB) Program.
Australian Manufacturing | 10 December 2019
This article highlights the launch of our report with Asialink Business and unpacking the India opportunity.
BioWorld | 7 June 2019
BioWorld highlights the Australian delegation to BIO international convention and also features the How Global MedTech & Pharma Corporates Engage with Australia report in partnership with BioPacific Partners.
Business News | 4 June 2019
One year on from creating the MTPConnect WA Hub, the story examines the achievements of the Hub in partnership with the WA Government and UWA.
Stockhead | 8 March 2019
Stockhead profiles MTPConnect's Chair Sue MacLeman on International Women's Day.
InnovationAus | 21 February 2019
The story tracks the growth of MTPConnect from it's beginnings as part of the Department of Industry, Innovation and Science's Industry Growth Centre initiative.
Department of Health | 18 February 2019
The Australian Government announced the development of the Biomedical Translation Bridge (BTB) Program with partners including, BioCurate, UniQuest, the Medical Device Partnering Program (MDPP) and the Bridge Program.
Biotech Dispatch | 17 January 2019
MTPConnect has backed its project ANDHealth to continue its work on enhancing the Australian digital health sector.
Biotech Dispatch (also featured in Pharma Dispatch) | 20 December 2018
MTPConnect CEO authored a blog for Biotech Dispatch on the new features in the MRFF and the possibilities for the future that was announced in December.
Biotech Dispatch | 6 Decemember 2018
When it was announced that MTPConnect would receive additional funding to 2021, AusBiotech congratulated MTPConnect on the great news.
The Mandarin | 16 November 2018
MTPConnect CEO Dr Dan Grant wrote an opinion piece on regenerative medicine in Australia and what opportunities there are for the sector.
The Australian | 31 October 2018
The Australian exclusively covered the launch of our regenerative medicine report at the AusBiotech Conference.
Healthcare IT | 16 October 2018
Three MTPConnect projects - the Industry Mentoring Network in STEM (IMNIS), the Medical Device Partnering Program (MDPP) and Asialinks Business - have received funding from the MTPConnect Project Fund Program. IMNIS and MDPP were part of the 2016 round of the program and Asialinks is a new project.
BioSpace | 4 October 2018
International publication BioSpace shared the announcement of MTPConnect's new chair Sue MacLeman, taking over from our Chair Dr Bronwyn Evans who is stepping down after nearly two years of service.
BioWorld | 25 September 2018
BioWorld journalist Tamra Sami interviewed MTPConnect CEO Dr Dan Grant in WA around the launch of the MTPConnect WA hub in September.
The Australian Financial Review | 30 July 2018
Former Minister for Jobs and Innovation Senator Michaelia Cash wrote an opinion piece for the AFR in July around the AFR Innovation Summit.
Manufacturer's Monthly | 4 July 2018
MTPConnect's Chair Dr Bronwyn Evans supported the launch of the MTPConnect WA Node in partnership with the Western Australian Government and the University of Western Australia at the Harry Perkins Institute and Centre for Medical Research.
Nature Journal | 9 May 2018
MTPConnect CEO Sue MacLeman spoke with Nature, a scientific journal about how Australia is making its mark in biotechnology.
Lab and Life Scientist | 7 May 2018
Dr Dan Grant was announced as MTPConnect's CEO-elect bringing with him many years of experience in the sector, where he will be starting in July.
Healthcare IT | 19 April 2018
MTPConnect's CEO Sue MacLeman talks to Healthcare IT about the recent announcement of the amazing innovations of the MTPConnect-delivered, Department of Health's $10 million BioMedTech Horizons program.
Illawara Mercury | 19 April 2018
The article focuses on the team behind the Biopen, one of the 11 selected participants who have received funding from the MTPConnect-delivered Department of Health's $10 million BioMedTech Horizons program.
Manufacturer's Monthly | 18 April 2018
MTPConnect and the Minister for Health, Greg Hunt, have announced the first 11 recipients of $10 million investment from the government’s $35 million BioMedTech Horizons program.
Manufacturer's Monthly | 12 April 2018
MTPConnect and BioPacific Partners has jointly launched an exciting new initiative to assist Australian medical technology and pharmaceutical companies to better prepare and position themselves to engage successfully with multinational companies.
Chinese demand has sparked ASX-listed food and resources stocks — but health innovators may benefit most, says MTP Connect CEO Sue MacLeman. Ms MacLeman also mentions our Project Fund Program recipient's AusBiotech Asian Investment Series in Hong Kong and Shanghai.
InnovationAus | 8 March 2018
MTPConnect CEO Sue MacLeman talks to Innovation Australia about creating gender diversity within the tech and innovation sector or lose global competitiveness in this critical arena on International Women's Day.
Manufacturer's Monthly | 12 February 2018
MTPConnect has released new sector metrics that show jobs supported by the MTP sector increased by 10 per cent to 62,000 from 2015 to 2016, and that manufacturing exports are up by 30 per cent to $5.2 billion.
The Australian | 1 November 2017
Managed by MTPConnect, the $5m BioMedTech Horizons program will be managed by MTPConnect, the medical technologies and pharmaceuticals industry growth centre. MTPConnect chief executive Sue MacLeman spoke to The Australian, saying that 3D anatomical printing and precision medicine had been identified for the first share of funding because Australia punched above its weight in those areas.
Australian Financial Review | 26 October 2017
Our CEO Sue MacLeman talks about a MTPConnect Project Fund Program lead The Garvan Institute aimed to improve cancer clinical trial research.
Manufacturer's Monthly | 11 August 2017
Our General Manager of Education, Skills and Events Dr Melanie Thomson about the training that will save pharmaceutical manufacturing businesses time and money by allowing employees to transfer basic skills between companies.
The Mandarin | 7 August 2017
An article discussing our Clinical Trials Report and how it aims to turn Australia around to be a destination for jobs and pharmaceutical investment in clinical trials.
Business News Western Australia | 1 November 2016
The MTPConnect Project Fund Program has provided a local WA consortium with a $150,000 grant to improve commercialisation of pharmaceutical and medical technologies.
BioWorld | 28 October 2016
The Medical Technologies and Pharmaceuticals Industry Growth Centre (MTPConnect) announced at the recent AusBiotech annual conference that it would provide A$7.4 million (US$5.6 million) of funding over two years for 14 national projects in the med-tech, biotech and pharmaceutical sector, with the Australian government injecting more funding into its life sciences sector to help it become more globally competitive in commercializing products.
StartUp Smart | 24 October 2016
Growing investment in medical technology and pharmaceutical innovation is set to fire a new pipeline of high-impact ventures into Australia that have been hiding in the corridors of universities waiting to be commercialised. This week, non-profit organisation MTPConnect announced it will inject $7.4 million into 14 medtech, biotech and pharmaceutical projects over the next two years. The funding will be matched by a further $32 million from industry partners under MTP Connect’s project fund program.
Australian Financial Review | 26 September 2016
Our CEO Sue MacLeman comments on the recent Federal Government response to the Review of Medicines and Medical Devices Regulation in this article highlighting Johnson & Johnson's potential commercialisation of two winning inventions from a hackathon earlier this month.
InnovationAus | 30 June 2016
Our CEO Sue MacLeman talked to InnovationAus about the achievements and challenges of the MTP sector and how MTPConnect will increase collaboration and commercialisation efforts.
University of Sydney | 11 December 2015
Australia’s newest Growth Centre – the Medical Technologies and Pharmaceutical Industry Growth Centre – has been announced by the Hon. Christopher Pyne, Federal Minister for Industry, Innovation and Science and Minister for Health, Sussan Ley.